Truth Social is launching a predictions marketplace through a partnership with Crypto.com’s parent company. The move represents a significant expansion of Trump Media’s financial and media ambitions beyond traditional social networking.
A San Francisco startup called Substrate has raised $100 million to take on ASML’s monopoly in chip-making equipment. Their technology promises to cut costs in half, but can they really compete with a decade of industry dominance?
OpenAI has officially completed its transition to a for-profit corporation, marking a fundamental shift from its original non-profit mission. With Microsoft securing major intellectual property rights and a complex new governance structure, the AI lab’s future direction raises critical questions abo
UK tech lobby groups are issuing urgent warnings ahead of the November 26 budget, calling it a “make or break” moment for the sector. With taxes potentially rising to 54% for VCs and founders considering relocation, the government faces pressure to support scaling businesses.
Mercor’s valuation quintuples to $10B as AI labs scramble for specialized training data. The platform connects domain experts with AI companies, but faces scalability and quality control challenges in this emerging market.
Steven Bartlett’s Steven.com secured massive funding at €365M valuation to build the “Disney of creator economy.” But can individual creators truly become institutional businesses? Industry analysis reveals the challenges ahead.
Kenvue, the Johnson & Johnson consumer health spin-off, has seen its stock price collapse amid legal uncertainties and management turmoil. While the company’s strong brand portfolio and cash flow suggest value, significant risks remain for investors considering this dip.
Citi Ventures has built one of Wall Street’s most formidable corporate venture arms over 15 years, making 200+ investments and 30 exits. The operation balances financial returns with strategic technology development for Citibank’s evolving needs.
Stockholm-based Cellcolabs has raised €10.3 million to revolutionize stem cell accessibility through scalable manufacturing. The funding signals growing investor confidence in making regenerative medicine affordable and widely available. This could transform how research and therapies are developed
A former Nvidia executive’s bold prediction that AI could add $2.9 trillion to Africa’s economy faces scrutiny against infrastructure realities. While local AI development shows promise, the continent must overcome connectivity gaps and international skepticism to achieve its technological ambitions
